Limitations to the use of PD-L1 include its unknown significance in head and neck squamous cell carcinoma apart from oral cavity cancer, and the lack of data on the PD-L1 ligand in head and neck squamous cell carcinoma [108]. Here, CD274 is linked to head and neck squamous cell carcinoma.